Depression can affect more than a person’s mood. Persistent symptoms may interfere with sleep, concentration, motivation, relationships, work, and everyday responsibilities. While antidepressants and psychotherapy can help many people, some individuals continue to experience significant symptoms despite previous treatment.
For eligible adults with treatment-resistant depression, SPRAVATO treatment may be an additional option to discuss with a qualified psychiatric provider. SPRAVATO contains esketamine and is administered under medical supervision as part of a structured treatment plan.
Understanding the potential role of SPRAVATO, how treatment works, and what patients can expect can help people make more informed decisions about depression care.
What Is SPRAVATO Treatment?
SPRAVATO is a prescription nasal spray containing esketamine. It is used for specific depression-related indications and is administered in an appropriate healthcare setting under professional supervision.
Unlike many traditional antidepressants, esketamine works through the glutamate system in the brain. This different mechanism makes SPRAVATO a treatment option that may be considered for certain adults whose depression has not improved adequately with previous antidepressant treatment.
A psychiatric evaluation is necessary to determine whether SPRAVATO treatment for depression is appropriate for an individual patient.
What Is Treatment-Resistant Depression?
Depression treatment does not produce the same results for everyone. Some patients improve with their first medication, while others may need adjustments or different approaches.
When significant depressive symptoms continue despite appropriate treatment attempts, a provider may evaluate whether the patient has treatment-resistant depression.
Symptoms can include:
- Persistent low mood
- Loss of interest in activities
- Low motivation
- Fatigue
- Difficulty concentrating
- Sleep disturbances
- Appetite changes
- Feelings of hopelessness
- Difficulty managing everyday activities
A psychiatric provider can review previous treatment history and determine whether another treatment approach should be considered.
How Can SPRAVATO Relate to Depression Symptom Relief?
The goal of depression treatment is to reduce symptoms and improve overall functioning. SPRAVATO offers a different mechanism from many conventional antidepressants and may be considered for appropriately selected patients with treatment-resistant depression.
Esketamine is an NMDA receptor antagonist that affects glutamate signaling in the brain. This is different from the primary mechanisms of many traditional antidepressant medications.
Patients interested in understanding the science behind treatment can read how SPRAVATO works for depression for additional information about its mechanism and treatment process.
What Happens During SPRAVATO Treatment?
SPRAVATO is administered as a nasal spray while the patient is under professional supervision.
Before administration, the healthcare team may assess the patient’s condition and check blood pressure. After receiving the medication, the patient remains at the healthcare facility for observation.
This monitoring is important because temporary effects may occur, including:
- Dissociation
- Dizziness
- Sedation
- Nausea
- Increased blood pressure
- Headache
- Anxiety
Patients should follow their provider’s instructions regarding driving and other activities following treatment.
How Long Does SPRAVATO Treatment Take?
SPRAVATO is generally administered through a structured course rather than as a one-time treatment.
The frequency of sessions can vary depending on the stage of treatment and the patient’s response. A psychiatric provider monitors progress and determines whether continued treatment is appropriate.
Because patients respond differently, treatment should be individualized rather than based on a predetermined expectation of results.
Who May Consider SPRAVATO?
SPRAVATO treatment for depression may be considered for eligible adults with treatment-resistant depression.
A provider may evaluate:
- Previous antidepressant treatments
- Response to previous medications
- Current depression symptoms
- Medical history
- Current medications
- Blood pressure
- Other relevant health conditions
- Individual treatment goals
SPRAVATO is not appropriate for everyone. Certain medical conditions and medications may affect eligibility, making a professional evaluation essential.
Potential Benefits of Esketamine Therapy
For appropriately selected patients, esketamine therapy offers several potential advantages.
A Different Mechanism
Esketamine affects the glutamate system rather than primarily targeting the neurotransmitter pathways associated with many traditional antidepressants.
Supervised Treatment
SPRAVATO is administered in a healthcare setting where patients can be monitored during and after treatment.
An Option After Previous Treatment
Patients who have not achieved adequate improvement with conventional antidepressants may have SPRAVATO discussed as another potential treatment option.
Individualized Care
A provider can assess symptoms and monitor treatment response throughout the course of care.
What Should Patients Expect After Treatment?
Patients may experience temporary effects after receiving SPRAVATO. This is why observation is an important part of the treatment process.
The healthcare team can monitor the patient’s condition and provide appropriate guidance before they leave the facility.
Patients should arrange transportation when required and follow all instructions provided by their healthcare professional.
SPRAVATO and a Broader Depression Treatment Plan
SPRAVATO does not necessarily represent the entire treatment plan for depression.
Depending on the individual’s needs, psychiatric care may also involve psychotherapy, medication management, lifestyle changes, or other forms of mental health support.
The appropriate combination depends on the patient’s diagnosis, treatment history, symptoms, and overall health.
Finding Personalized Depression Treatment
Patients who continue to experience depression symptoms after trying conventional treatments may benefit from discussing additional options with a qualified psychiatric provider.
Family Care Psychiatry provides individualized psychiatric care and treatment options for patients dealing with depression and other mental health concerns.
The practice proudly serves patients from Ann Arbor, Canton, Brighton, Plymouth, Ypsilanti, and Chelsea, as well as surrounding communities across Washtenaw County, Wayne County, Livingston County, and Jackson County.
For people researching depression treatment options, a comprehensive evaluation can help determine which approaches may be appropriate based on their individual circumstances.
Final Thoughts
Depression symptom relief can look different for every patient. When conventional antidepressant treatment has not provided adequate improvement, eligible adults with treatment-resistant depression may have additional options to discuss with a psychiatric provider.
SPRAVATO treatment uses esketamine and works through a different mechanism from many traditional antidepressants. Because it requires supervised administration and careful patient selection, treatment should always be provided under appropriate medical guidance.
If you’re considering SPRAVATO treatment for depression, speaking with a qualified psychiatric professional can help you understand the potential role of this treatment and whether it fits your individual treatment plan.
